Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine and nonmodulating hypertension.

G H Williams1, M S Gordon, C A Stuenkel

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.

American Journal of Hypertension
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive milestones across the lifespan and cardiovascular disease risk in women.

Climacteric : the journal of the International Menopause Society·2023
Same author

Compounded bioidentical menopausal hormone therapy - a physician perspective.

Climacteric : the journal of the International Menopause Society·2020
Same author

Do we have new preventive strategies for optimizing cardiovascular health in women?

Climacteric : the journal of the International Menopause Society·2019
Same author

Menopause, hormone therapy and diabetes.

Climacteric : the journal of the International Menopause Society·2017
Same author

Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women.

Journal of human hypertension·2013
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
Same journal

Estimated Pulse Wave Velocity Predicts Outcomes After Acute Ischemic Stroke: A Multinational Cohort Analysis.

American journal of hypertension·2026
See all related articles

Nonmodulating hypertension involves higher dopamine levels, but dopamine does not explain the reduced aldosterone response to angiotensin II (AII). Sodium intake affects dopamine levels differently in hypertensive nonmodulators.

Area of Science:

  • Endocrinology
  • Nephrology
  • Hypertension Research

Background:

  • Sodium intake significantly influences aldosterone secretion and its response to angiotensin II (AII).
  • Dopamine is implicated in inhibiting aldosterone secretion, potentially mediating sodium-induced alterations in AII responsiveness.
  • Nonmodulating hypertension exhibits diminished aldosterone responses to AII, suggesting a possible role for enhanced dopaminergic inhibition.

Purpose of the Study:

  • To investigate if increased dopaminergic inhibition underlies the adrenal defect in nonmodulating hypertension.
  • To assess the physiological relevance of dopamine levels in hypertensive patients' modulation status.
  • To compare the impact of dietary sodium intake on urinary dopamine levels in normotensive and hypertensive subjects.

Main Methods:

Related Experiment Videos

  • Characterized 69 hypertensive patients based on their modulation status on a low sodium intake.
  • Administered dopamine antagonist metoclopramide to 13 patients to assess aldosterone response to AII before and during treatment.
  • Compared urinary dopamine levels in response to high sodium intake in modulators, nonmodulators, and normotensive subjects.

Main Results:

  • Nonmodulating hypertensive patients had significantly higher dopamine levels compared to modulators.
  • Metoclopramide administration did not alter the aldosterone response to AII in either hypertensive subgroup.
  • Normotensive and modulating subjects increased urinary dopamine excretion with high sodium intake, unlike nonmodulators.

Conclusions:

  • The adrenal defect in nonmodulating hypertension is unlikely due to increased dopamine levels.
  • Reduced intrarenal dopamine production in response to a sodium load may contribute to the sodium-retaining tendency of nonmodulators.